The 100 Top-Cited Scientific Papers Focused on the Topic of Bacteriocins

Jamali, Hossein; Krylova, Kateryna; Dozois, Charles M.

doi:10.1007/s10989-018-9741-6

Cited by 6 publications

(4 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results highlighted the great contributions and the predominant role of the United States in the development of antibiotic adjuvants. Similar results were also obtained in other bibliometric analyses of topics related to bacterial infection, such as tuberculosis, pneumonia, bacteriocins, and bacterial persisters (Chen et al, 2015;Jamali et al, 2019;Wang et al, 2019;Ju et al, 2022). As for the possible reasons, that is inseparable from significant investment by governments and pharmaceutical companies.…”

Section: General Informationsupporting

confidence: 80%

“…In particular, reviewing the "highly cited" or "top-cited" publications facilitates the identification of scientific excellence, outstanding authors or institution impacts, and discerning research hotspots (Jenkins et al, 2022;Li et al, 2022). Bibliometric analysis of the top 100 most-cited publications has offered insights into research related to antibacterial compounds, including dalbavancin (Monteagudo-Martínez et al, 2022), bacteriocins (Jamali et al, 2019), and antibiotics (Arshad et al, 2020). Although a bibliometric analysis has analyzed clavulanic acid-related studies (Ramirez-Malule, 2018), there is no citation analysis of the top-cited publications on antibiotic adjuvants.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis

Sun,

Xu,

Zhang

et al. 2023

Front. Pharmacol.

View full text Add to dashboard Cite

Background: The utilization of antibiotic adjuvants presents a promising strategy for addressing bacterial resistance. Recently, the development of antibiotic adjuvants has attracted considerable attention from researchers in academia and industry. This study aimed to identify the most influential publications on antibiotic adjuvants and elucidate the hotspots and research trends in this field.Method: Original articles and reviews related to antibiotic adjuvants were retrieved from the Web of Science Core Collection database. The top 100 highly cited publications were selected and the visual analyses of publication outputs, countries, institutions, authors, journals, and keywords were conducted using Excel, VOSviewer, or CtieSpace software tools.Results: The top 100 cited publications concerning antibiotic adjuvants spanned the years 1977–2020, with citation counts ranging from 174 to 2,735. These publications encompassed 49 original articles and 51 reviews. The journal “Antimicrobial Agents and Chemotherapy” accounted for the highest number of publications (12%). The top 100 cited publications emanated from 39 countries, with the United States leading in production. Institutions in Canada and the United States exhibited the most substantial contributions to these highly cited publications. A total of 526 authors participated in these studies, with Robert E.W. Hancock, Laura J. V. Piddock, Xian-Zhi Li, Hiroshi Nikaido, and Olga Lomovskaya emerging as the most frequently nominated authors. The most common keywords included “E. coli”, “P. aeruginosa”, “S. aureus”, “in-vitro activity”, “antimicrobial peptide”, “efflux pump inhibitor” “efflux pump”, “MexAB-OprM” and “mechanism”. These keywords underscored the hotspots of bacterial resistance mechanisms and the development of novel antibiotic adjuvants.Conclusion: Through the bibliometric analysis, this study identified the top 100 highly cited publications on antibiotic adjuvants. Moreover, the findings offered a comprehensive understanding of the characteristics and frontiers in this field.

show abstract

Section: General Informationsupporting

confidence: 80%

Section: Introductionmentioning

confidence: 99%

Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis

Sun,

Xu,

Zhang

et al. 2023

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…Although it is a fact that the current literature for bacteriocins produced from Gram-negative bacteria is dominated by bacteriocins toward Gram-positive bacteria ( Jamali et al, 2019 ), there is an acceptable amount of bacteriocins reported to have a strong activity against Gram-negative bacteria, including the pathogenic strains. For example, the S-type pyocin group from the P. aeruginosa ( Ghequire and De Mot, 2014 ) or the microcin and colicin groups that are vastly reported for E. coli , and other examples in less quantity but not less relevant, are bacteriocins produced by K. pneumoniae, Citrobacter freundii , Shigella boydii , and Serratia marcescens ( Yang et al, 2014 ).…”

Section: Future Trends In Bacteriocin Development and Designmentioning

confidence: 99%

Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in vivo Models

et al. 2021

View full text Add to dashboard Cite

The world is facing a significant increase in infections caused by drug-resistant infectious agents. In response, various strategies have been recently explored to treat them, including the development of bacteriocins. Bacteriocins are a group of antimicrobial peptides produced by bacteria, capable of controlling clinically relevant susceptible and drug-resistant bacteria. Bacteriocins have been studied to be able to modify and improve their physicochemical properties, pharmacological effects, and biosafety. This manuscript focuses on the research being developed on the biosafety of bacteriocins, which is a topic that has not been addressed extensively in previous reviews. This work discusses the studies that have tested the effect of bacteriocins against pathogens and assess their toxicity using in vivo models, including murine and other alternative animal models. Thus, this work concludes the urgency to increase and advance the in vivo models that both assess the efficacy of bacteriocins as antimicrobial agents and evaluate possible toxicity and side effects, which are key factors to determine their success as potential therapeutic agents in the fight against infections caused by multidrug-resistant microorganisms.

show abstract

“…A study of the 100 top-cited papers involving bacteriocins showed that nearly 80% are mainly concerned with bacteriocins from Gram-positive bacteria, while only nine described bacteriocins of Gram-negative bacteria. In addition, of all the works published in the Web of Science, only 26% fell into in the category of biotechnology and applied microbiology (Jamali, Krylova, & Dozois, 2019).…”

mentioning

confidence: 99%

Characterisation and action mode of Gluconacin, a bacteriocin with antimicrobial activity against Xanthomonas albilineans

Ramos

Meneses

Vidal

et al. 2021

Annals of Applied Biology

View full text Add to dashboard Cite

Gluconacin, a bacteriocin produced by Gluconacetobacter diazotrophicus PAL5, has previously shown a large spectrum of inhibitory activity against beneficial and phytopathogenic bacteria. The present study proposes a three-dimensional (3D) structure for Gluconacin based on modelling and describes some physicochemical characteristics and the effect of the peptide on cells of the phytopathogenic bacterium Xanthomonas albilineans ICMP196. The Gluconacin 3D structural model results demonstrated the 7 αhelices and 11 β-sheets. Growth inhibition of the indicator microorganism, X. albilineans, occurred in the first moments of contact with Gluconacin (0.25 μg μl À1 ). Treatment of bacterial cells caused significant loss of inorganic phosphate and UV-absorbing materials.Scanning electron microscopy images showed that Gluconacin-treated X. albilineans cells were fully lysed. These results suggest that the mode of action of this peptide involves altered membrane integrity and increased permeability, resulting in complete cell lysis.Physicochemical characterisation demonstrated stability of biological activity under high temperatures, including autoclaving conditions and low pH. The activity was reduced after treatment with proteases and some surfactants and abolished with ethylenediaminetetraacetic acid (EDTA). The 3D conformation model indicates the possibility of a hydrophobic region, which could possibly interact directly with the cell membrane of target bacteria. In conclusion, the ability of Gluconacin to inhibit growth of phytopathogens of agricultural importance opens up new opportunities for biotechnological applications and, consequently, a reduction in the use of pesticides.

show abstract

The 100 Top-Cited Scientific Papers Focused on the Topic of Bacteriocins

Cited by 6 publications

References 26 publications

Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis

Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis

Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in vivo Models

Characterisation and action mode of Gluconacin, a bacteriocin with antimicrobial activity against Xanthomonas albilineans

Contact Info

Product

Resources

About